Minerva Surgical, Inc. (UTRS) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to the Nerva Surgical Q2 2023 earnings call. At this time, all participants are in listen-only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Caroline Korner, Investor Relations. Thank you, Mel. You may begin. Thank you, Operator. Welcome to Minerva's second quarter 2023 earnings call. Joining me on today's call are Todd Youssen, President and Chief Executive Officer, and Joe Young, Chief Financial Officer. This call will provide forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Minerva Surgical operates, trends and expectations for Minerva's products and technology, trends and demand for Minerva's products, Minerva's expected financial performance, expenses and position in the market, and outlook for fiscal year 2023. These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by the forward-looking statements. Please review Minerva's most recent filings with the SEC for additional information, particularly the risk factors described in Minerva's quarterly report on Form 10-Q for the quarter ended March 31, 2023, which was filed on May 3, 2023, and will be updated in the company's quarterly report on Form 10-Q for the quarter ended June 30, 2023, whi...